1-(THIENYLALKYL)IMIDAZOLE-2(3H)-THIONES AS POTENT COMPETITIVE INHIBITORS OF DOPAMINE BETA-HYDROXYLASE

被引:8
|
作者
MCCARTHY, JR
MATTHEWS, DP
BROERSMA, RJ
MCDERMOTT, RD
KASTNER, PR
HORNSPERGER, JM
DEMETER, DA
WEINTRAUB, HJR
WHITTEN, JP
机构
[1] MERRELL DOW RES INST,INDIANAPOLIS,IN 46268
[2] MERRELL DOW RES INST,F-67084 STRASBOURG,FRANCE
关键词
D O I
10.1021/jm00169a006
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
1-(2-Thienylalkyflimidazole-2(3H)-thiones (5a—k) are competitive inhibitors of dopamine 0-hydroxylase (DBH) and demonstrate the utility of thiophene in the design of potent competitive inhibitors of this enzyme. The structure—activity relationships for these compounds are discussed and compared with those of 1-phenylalkyl-imidazole-2(3H)-thiones (1). With the aid of molecular modeling, an idealized active-site conformer is proposed and an explanation for the difference in activity between the phenyl (1) and thienyl (5) DBH inhibitors is presented. The difference in activity is consistent with our proposal that thiophene may not always be a bioisostere for phenyl. The inhibitor of most interest, 1-[2-(2-thienyl)ethyl] imidazole-2 (3H)-thione (5g), was selected for study in the spontaneously hypertensive rat. The changes in dopamine and norepinephrine levels that resulted from oral administration of 5g correlated with the reduction of blood pressure. © 1990, American Chemical Society. All rights reserved.
引用
收藏
页码:1866 / 1873
页数:8
相关论文
共 50 条
  • [41] SYNTHESIS OF SEVERAL 2-SUBSTITUTED 3-(PARA-HYDROXYPHENYL)-1-PROPENES AND THEIR CHARACTERIZATION AS MECHANISM-BASED INHIBITORS OF DOPAMINE BETA-HYDROXYLASE
    RAJASHEKHAR, B
    FITZPATRICK, PF
    COLOMBO, G
    VILLAFRANCA, JJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1984, 259 (11) : 6925 - 6930
  • [42] SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF A SERIES OF DIHYDRO-1H-PYRROLO[1,2-A]IMIDAZOLE-2,5(3H,6H)-DIONES, A NOVEL CLASS OF POTENT COGNITION ENHANCERS
    PINZA, M
    FARINA, C
    CERRI, A
    PFEIFFER, U
    RICCABONI, MT
    BANFI, S
    BIAGETTI, R
    POZZI, O
    MAGNANI, M
    DORIGOTTI, L
    JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (26) : 4214 - 4220
  • [43] 4-Phenyl-1H-imidazole-2(3H)-thione
    Owczarzak, Anita M.
    Kubicki, Maciej
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O1686 - +
  • [44] Synthesis, structure, Hirshfeld surface, crystal voids, energy framework and DFT analysis of 1H-benzo[d]imidazole-2(3H)-thione
    Singh, M.
    Anthal, S.
    Kamal
    Deshmukh, M. B.
    Kant, Rajni
    INDIAN JOURNAL OF CHEMISTRY, 2022, 61 (05): : 528 - 536
  • [45] ACTIVE-SITE LABELING OF DOPAMINE BETA-HYDROXYLASE BY 2 MECHANISM-BASED INHIBITORS - 6-HYDROXYBENZOFURAN AND PHENYLHYDRAZINE
    FARRINGTON, GK
    KUMAR, A
    VILLAFRANCA, JJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1990, 265 (02) : 1036 - 1040
  • [46] Crystal structure of 1-methyl-5-(trifluoromethyl)-1H-benzo[d]imidazole-2(3H)-thione, C9H7F3N2S
    Zhu, Guang-Zhou
    Lu, Zai-Sheng
    Shi, Huan-Le
    Wang, Xiang-Shan
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2013, 228 (02): : 187 - 188
  • [47] 1,3-Bis(naphthalen-2-ylmethyl)-1H-anthra[1,2-d]imidazole-2,6,11(3H)-trione
    Afrakssou, Zahra
    Rodi, Youssef Kandri
    Capet, Frederic
    Essassi, El Mokhtar
    Ng, Seik Weng
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O2138 - U1444
  • [48] 1,3-Bis(prop-2-yn-1-yl)-1H-anthra[1,2-d]imidazole-2,6,11(3H)-trione
    Afrakssou, Zahra
    Haoudi, Amal
    Capet, Frederic
    Mazzah, Ahmed
    Rolando, Christian
    El Ammari, Lahcen
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O944 - +
  • [49] 1-[(Benzofuran-2-yl)phenylmethyl]-triazoles and -tetrazoles - potent competitive inhibitors of aromatase
    Vinh, TK
    Ahmadi, M
    Delgado, POL
    Perez, SF
    Walters, HM
    Smith, HJ
    Nicholls, PJ
    Simons, C
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (14) : 2105 - 2108
  • [50] 2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives: Novel, potent and selective sigma(1) receptor ligands
    Ucar, H
    Cacciaguerra, S
    Spampinato, S
    Vanderpoorten, K
    Isa, M
    Kanyonyo, M
    Poupaert, JH
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 335 (2-3) : 267 - 273